JOURNEY II BCS
Device
Smith+Nephew, Inc.
Total Payments
$7.2M
Transactions
710
Doctors
249
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $4.2M | 346 | 140 |
| 2020 | $3.0M | 364 | 138 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $5.1M | 20 | 71.1% |
| Unspecified | $1.4M | 49 | 19.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $548,101 | 179 | 7.6% |
| Consulting Fee | $53,726 | 17 | 0.7% |
| Travel and Lodging | $40,009 | 144 | 0.6% |
| Food and Beverage | $18,169 | 297 | 0.3% |
| Space rental or facility fees (teaching hospital only) | $2,415 | 2 | 0.0% |
| Debt forgiveness | $1,108 | 2 | 0.0% |
Payments by Type
General
$5.8M
661 transactions
Research
$1.4M
49 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| In Vivo Kinematic Analysis of Cruciate Retaining, Posterior Cruciate Substituting and ACL-PCL Retaining Bi-Cruciate Total Knee Arthroplasty | Smith+Nephew, Inc. | $403,528 | 0 |
| Establishment of implant outcomes data registry | Smith+Nephew, Inc. | $361,640 | 0 |
| Smith and Nephew Clinical Data Registry | Smith+Nephew, Inc. | $242,499 | 0 |
| Journey 2 vs. Standard PS Knee | Smith+Nephew, Inc. | $87,495 | 0 |
| Long Term Outcomes of Journey II BCS Constrained Liner | Smith+Nephew, Inc. | $83,050 | 0 |
| A Critical Assessment of the Factors That Promote or Limit the Return to Recreational, Work, and Physical Fitness Activities after Primary Total Knee Arthroplasty | Smith+Nephew, Inc. | $82,188 | 0 |
| Assessment of JOURNEY II TKA to improve knee range of motion, patient reported outcomes, muscle strength and joint kinematics | Smith+Nephew, Inc. | $77,539 | 0 |
| A Retro-Prospective, Non-randomized, Consecutive Series, SIngle Cohort, Multicenter Adaptive Design Study to Evaluate the Outcomes of Total Knee Arthroplasty TKA Using JOURNEY II BCS Total Knee System The NIMBLE study | Smith+Nephew, Inc. | $33,982 | 0 |
| Journey II Bi-Cruciate Stabilized (BCS) Knee System | Smith+Nephew, Inc. | $21,500 | 0 |
| Safety and Performance of Journey II BCS Total Knee System A Retrospective Multicenter Study | Smith+Nephew, Inc. | $8,000 | 0 |
| Retrospective Data Capture Activity to Collect Safety and Clinical Outcomes in subjects implanted with the JOURNEY II Knee System with LEGION Revision Tibial Baseplate | Smith+Nephew, Inc. | $3,470 | 0 |
| Data relating to the JOURNEY II Knee System with LEGION Revision Tibial Baseplate | Smith+Nephew, Inc. | $2,000 | 0 |
| Journey II BCS Safety and Efficacy Study | Smith+Nephew, Inc. | $1,670 | 0 |
| Patient Reported Outcome Measurment Information System (PROMIS) Comuter Adaptive Test (CAT) domains-Validation and comparison with the Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS,JR.) in the total knee arthroplasty | Smith+Nephew, Inc. | $1,083 | 0 |
Top Doctors Receiving Payments for JOURNEY II BCS — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Kenneth Urish | Orthopaedic Surgery | Pittsburgh, PA | $7,200 | 3 |
| , M.D., M.SC | General Acute Care Hospital | Orange, CA | $6,750 | 3 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Temple Terrace, FL | $6,188 | 1 |
| Steven Weeden | — | Fort Worth, TX | $5,750 | 1 |
| , M.D | Orthopaedic Surgery | Salt Lake City, UT | $5,403 | 3 |
| , M.D | Orthopaedic Surgery | Morton Grove, IL | $5,250 | 3 |
| , MD | Sports Medicine | Honolulu, HI | $5,200 | 1 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Rancho Mirage, CA | $5,100 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Morrisville, VT | $4,980 | 3 |
| , M.D | Orthopaedic Surgery | Orange, CA | $4,872 | 4 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Chicago, IL | $4,856 | 1 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Portland, OR | $4,250 | 1 |
| , M.D | Orthopaedic Surgery | New York, NY | $4,111 | 3 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Chicago, IL | $4,104 | 6 |
| , M.D | Orthopaedic Surgery | New York, NY | $4,025 | 1 |
| , MD | Orthopaedic Surgery | Knoxville, TN | $4,000 | 1 |
| , MD | Orthopaedic Surgery | Tupelo, MS | $3,700 | 2 |
| , M.D | Orthopaedic Trauma | Bellevue, WA | $3,665 | 2 |
| , M.D | Orthopaedic Surgery | Van Nuys, CA | $3,560 | 2 |
| , M.D | Anesthesiology | Naperville, IL | $3,475 | 2 |
| , M.D | Orthopaedic Surgery | Oak Park Heights, MN | $3,100 | 1 |
| , MD | Orthopaedic Surgery | Overland Park, KS | $2,610 | 2 |
| , M.D | Orthopaedic Surgery | Pikeville, KY | $2,000 | 1 |
| , M.D | Orthopaedic Surgery | Baltimore, MD | $2,000 | 1 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | San Diego, CA | $1,800 | 1 |
Ad
Manufacturing Companies
- Smith+Nephew, Inc. $7.2M
Product Information
- Type Device
- Total Payments $7.2M
- Total Doctors 249
- Transactions 710
About JOURNEY II BCS
JOURNEY II BCS is a device associated with $7.2M in payments to 249 healthcare providers, recorded across 710 transactions in the CMS Open Payments database. The primary manufacturer is Smith+Nephew, Inc..
Payment data is available from 2020 to 2021. In 2021, $4.2M was paid across 346 transactions to 140 doctors.
The most common payment nature for JOURNEY II BCS is "Royalty or License" ($5.1M, 71.1% of total).
JOURNEY II BCS is associated with 14 research studies, including "In Vivo Kinematic Analysis of Cruciate Retaining, Posterior Cruciate Substituting and ACL-PCL Retaining Bi-Cruciate Total Knee Arthroplasty" ($403,528).